BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Chemicals/Chemical Industry CHM
Monitor legislative issues and administrative action related to the chemical industry.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD J BARRON | — |
| CHRISTOPHER LEAHY | — |
| LUCAS TOMANELLI | — |
Trade (domestic/foreign) TRD
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CORCORAN | — |
| CHRISTOPHER LEAHY | — |
| BRIAN MCCULLOUGH | — |
| JAMES P MCVANEY | — |
| LINDSAY A. MORRIS | — |
| LUCAS TOMANELLI | — |
| URSULA WOJCIECHOWSKI | — |
Agriculture AGR
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD J BARRON | — |
| CHRISTOPHER LEAHY | — |
| JAMES P MCVANEY | — |
| LINDSAY A. MORRIS | — |
| BRIAN NAGLE | — |
| PETER STEHOUWER | — |
| LUCAS TOMANELLI | — |
| URSULA WOJCIECHOWSKI | — |
Taxation/Internal Revenue Code TAX
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER LEAHY | — |
| BRIAN MCCULLOUGH | — |
| LINDSAY A. MORRIS | — |
| PETER STEHOUWER | — |
| URSULA WOJCIECHOWSKI | — |
Copyright/Patent/Trademark CPT
Monitor legislative and administrative action related to intellectual property protection.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD J BARRON | — |
| JULIE CORCORAN | — |
| CHRISTOPHER LEAHY | — |
| BRIAN MCCULLOUGH | — |
| BRIAN NAGLE | — |
| URSULA WOJCIECHOWSKI | — |
Health Issues HCR
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administration action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3921, HEALTHY KIDS Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CORCORAN | — |
| CHRISTOPHER LEAHY | — |
| BRIAN MCCULLOUGH | — |
| LINDSAY A. MORRIS | — |
| BRIAN NAGLE | — |
| PETER STEHOUWER | — |
Medicare/Medicaid MMM
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CORCORAN | — |
| CHRISTOPHER LEAHY | — |
| LINDSAY A. MORRIS | — |
| BRIAN NAGLE | — |
| PETER STEHOUWER | — |
Budget/Appropriations BUD
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD J BARRON | — |
| JULIE CORCORAN | — |
| CHRISTOPHER LEAHY | — |
| BRIAN MCCULLOUGH | — |
| JAMES P MCVANEY | — |
| BRIAN NAGLE | — |
| URSULA WOJCIECHOWSKI | — |
Government Issues GOV
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD J BARRON | — |
| CHRISTOPHER LEAHY | — |
| JAMES P MCVANEY | — |
Tariff (miscellaneous tariff bills) TAR
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD J BARRON | — |
| CHRISTOPHER LEAHY | — |
| BRIAN MCCULLOUGH | — |
| JAMES P MCVANEY | — |
| URSULA WOJCIECHOWSKI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.